MedCity News
NOVEMBER 12, 2023
To digitize healthcare and lean on the emerging technologies is to find the opportunity within the relationship between machine and human to augment humans’ ability to be human – to empathize and provide the compassionate touch to care.
PM360
NOVEMBER 12, 2023
PM360 asked Ivy Cohen, President and CEO, Ivy Cohen Corporate Communications, about the place she just can’t stop returning to. Ivy and her mother join in to choose the finale winner. My Odyssey: For the past seven years (with a couple year COVID gap), my husband, mother, and I attend Amateur Night at The Apollo—The Grand Finale on the night before Thanksgiving.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
NOVEMBER 12, 2023
Takeda Pharmaceutical enzyme replacement drug Adzynma is the first FDA-approved therapy for a rare blood disorder affecting fewer than 1,000 Americans. Our regulatory recap also includes the much-anticipated approval of an Eli Lilly weight loss drug and a crackdown on what the FTC says are improperly listed pharma product patents.
PM360
NOVEMBER 12, 2023
Here’s the fact: since the pandemic, launch revenues in pharma have declined. Doesn’t matter if it is specialty or primary care whether it’s the U.S. or the rest of the world, they’ve declined. The question is: What do you do to maximize the success of your launch? After a review of the professional literature and great advice from several colleagues in pharma, here are several things I would recommend.
MedCity News
NOVEMBER 12, 2023
In this episode, we’re joined by Melissa Tran, a marriage and family therapist and the military sexual trauma coordinator at the Orlando VA. She’s here to discuss the unique challenges female veterans face and the programs she’s helping build for this population.
PM360
NOVEMBER 12, 2023
While the global biopharma industry retains its huge dependence on the U.S. market, emerging markets present great opportunities for biotech and pharmaceutical companies. Development—and in particular, urbanization—means these markets offer greater potential than in the past. These markets often have larger populations than more established markets and higher population growth.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PM360
NOVEMBER 12, 2023
Data clearly matters in pharma. For the fourth year in a row artificial intelligence (AI) and Big Data ranked as the most impactful technologies in the industry, according to GlobalData’s “The State of the Biopharmaceutical Industry – 2023” report, which includes feedback from 198 companies. On top of that, the life sciences analytic market is expected to surpass $45.1 billion by 2030, according to ReportLinker.
MedCity News
NOVEMBER 12, 2023
It is important to understand that the performance of over-the-counter hearing aids can vary widely from prescription hearing aids due to a number of factors.
PM360
NOVEMBER 12, 2023
PM360 asked data experts what hidden insights companies may already have if they just know how to look for it as well as the best way to get buy-in on predictive analytics or next best action recommendations. Specifically, we wanted to know: As we undergo a data revolution in terms of the volume of data now at our exposure and the tools to analyze it, what is the biggest unrealized potential hidden in a company’s data assets?
pharmaphorum
NOVEMBER 12, 2023
AHA: Wegovy improves survival in outcomes trial Phil.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
PM360
NOVEMBER 12, 2023
The pharmaceutical marketing landscape is fast-moving and ever-evolving. New entrants come into a therapeutic class, often with increased efficacy or safety, while older products lose patent exclusivity, changing the promotional landscape. Plus, the ways healthcare providers (HCPs) interact with both patients and pharmaceutical companies have seen significant changes.
Pharmacy Times
NOVEMBER 12, 2023
The American Heart Association published a statement describing the cardiovascular-kidney-metabolic (CKM) construct, specifically highlighting treatment challenges for CKM syndrome.
PM360
NOVEMBER 12, 2023
Technological innovations and changes in consumer behavior over the past 10 years have reduced friction, saved time, and opened new options for consumers and patients seeking routine prescriptions and refills via telehealth. Let’s face it, most consumers seek convenience wherever they can find it. For routine healthcare, that often means skipping the doctor’s office if the individual can be qualified by an HCP via virtual care and then seamlessly receive the prescription (when medically appropri
PM360
NOVEMBER 12, 2023
PM360 asked Kara Bissonnette, Marketing Manager, Saatchi & Saatchi Wellness, about the place she just can’t stop returning to. My Odyssey: Anyone who’s ever met me knows I rant and rave about the state I grew up in—Rhode Island. An idyllic little slice of the northeast, smallest state in the nation (yes state, not island) and best kept secret. You can’t drive more than 10 miles without catching a glimpse of the ocean (the state has over 400 miles of coastline, which is the basis of its epith
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
PM360
NOVEMBER 12, 2023
Pharma brands are increasingly humanizing the patient journey today unlike ever before. The growing emphasis on more strategically aligning doctor data with patient advertising targeting is leading to better and more impactful experiences that more deeply consider the “why” behind how people approach their health. But for pharma marketers, aligning operations with the ethos of health, well-being, and responsibility shouldn’t end with serving the right ads to consumers.
PM360
NOVEMBER 12, 2023
In the current regulatory landscape, pharmaceutical marketers may be looking back fondly on the days when HIPAA and HITECH were the only laws related to data privacy. But that landscape is changing fast, triggered largely by the California Consumer Privacy Act (CCPA). “California started, and just about every state in the union now is looking at some sort of legislation at the state level because HIPAA doesn’t cover everything that consumers are concerned with when it comes to privacy,” explains
Expert insights. Personalized for you.
113 
Let's personalize your content